Condensed and Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income attributable to ordinary shares	$ 1,088,926	$ 102,877,786
Changes in operating assets and liabilities:
Reimbursement receivable	17,014,631
Prepaid expenses	(24,298)	39,452
Change in fair value of derivative assets	543,677
Accrued professional fees and other expenses	(5,930,402)	2,928,285
Change in fair value of derivative liabilities	(1,918,866)	(106,413,646)
Interest on investments held in Trust Account	(28,566)	(5,260)
Net cash provided by (used in) operating activities	10,745,102	(573,383)
Cash flows from financing activities:
Proceeds of note payable from Sponsor		2,000,000
Repayment of note payable from Sponsor	(6,000,000)
Net cash provided by (used in) financing activities	(6,000,000)	2,000,000
Net change in cash	4,745,102	1,426,617
Cash at beginning of period	1,133,113	669,767
Cash at end of period	$ 5,878,215	$ 2,096,384